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There are approximately 17 million cancer survivors living in the United States and by 2040 this 
estimate is predicted to increase to 26.1 million.1 Exercise provides a myriad of health benefits 
to individuals during and after cancer treatment by reducing treatment-related symptoms, 
improving functional status and quality of life, and lowering risk of disease recurrence.2,3 
Despite the established benefits, an individual’s level of physical activity often decreases during 
treatment and does not return to pre-diagnosis levels after treatment completion.4,5 While 
exercise is regarded as safe and beneficial for individuals with cancer, promoting exercise for 
this population is complex. A patient-centered pathway is needed that can guide oncology and 
primary care professionals in efficient assessment of an individual’s condition and enable 
personalized referrals for exercise interventions that promote physical activity. The purpose of 
this manuscript is to provide a framework for clinical decision making that enables personalized 
condition assessment, risk stratification, and referral to optimal settings for exercise promotion 
for cancer survivors. Implementation strategies are also offered to support the integration of 
this model into an oncology clinical workflow.
With guidance from their medical provider, individuals are more likely to engage in 
exercise and maintain levels of physical activity during cancer treatments.6 However, the 
number of individuals with cancer who report receiving exercise-specific guidance from their 
health care providers is low.7 Of particular concern is the lack of knowledge and training among 
health care professionals about exercise prescription for this complex population.8
Condition Complexity and Exercise Prescription 






























































The concurrence of cancer treatment-related side effects with pre-existing health conditions 
often makes it difficult for individuals to engage in physical activity and exercise.9-12 
Furthermore, motivation,13 environmental constraints, and concerns about safety during cancer 
medical therapies are barriers that challenge exercise engagement.14 15 In the case of exercise, 
it is widely recognized that one size does not fit all. A safe and well-designed exercise 
prescription for an individual at one point in the treatment continuum may not be safe or 
tenable further into treatment. Cancer care is dynamic and warrants personalized treatment 
pathways that individualize interventions, particularly regarding exercise, as the individual’s 
medical status and personal needs change.16-18 
Characterizing the individual’s prior level of function, exercise habits and lifestyle 
behaviors, preexisting comorbid conditions, and environment at the point of diagnosis provides 
important context to inform personalized exercise recommendations. A pragmatic approach to 
promote exercise is to then repeatedly screen for clinically meaningful changes in these 
baseline measures and refer for exercise prescription when indicated. Proactively prescribing 
exercise throughout cancer treatment may prevent the onset of some symptoms and mitigate 
the progressive severity of treatment-related functional impairments.19,20 
Numerous care models promote proactive assessment and referral for exercise and 
rehabilitation interventions for individuals with cancer. These models address referral based on 
presence of physical and functional impairment,21-23 age-related senescence,24 adverse side 
effects of cancer treatments,25,26 and many propose skilled interventions based on level of risk 
for treatment-related functional decline27-30 or impairment burden.18,31 Our core author team 
(NS/JB/TM/AS) conducted an evidence review of these models and identified common 






























































components that promoted prospective assessment for rehabilitative and exercise referrals in 
oncology specifically identifying evidence for risk stratification, screening and assessment, 
triage concepts and pathways, and implementation strategies. These findings were reviewed 
with the entire author team over the course of two teleconference discussions. The decision 
was made by consensus to work in teams to synthesize the evidence to support an exercise 
clinical pathway focusing on (i) screening for risk stratification (JB/KBE/JM/JL), (ii) referral 
pathways (NS/CA/JS/DZ), and (iii) implementation (AS/KS/LN/AC). These three areas were 
prioritized as the most impactful to guiding oncology or primary care professionals in 
promoting exercise referral. The concept of individual assessment for exercise interventions 
(TM/AC/GC/KC) informed the final manuscript but was decided to be beyond the scope of this 
manuscript and will be addressed in future work. Based on this review, we propose five 
domains to inform a personalized exercise clinical pathway. 
Five Domains to Guide Decision Making 
The five domains provide perspective on the complexity of an individual’s condition, 
characterize risk for exercise-related complications, and guide clinical decision making for 
individualized recommendations. The domains include cardiometabolic status, oncologic 
factors, aging considerations, behavioral characteristics, and environmental elements. The 
confluence of presenting symptoms within and across domains influences the exercise 
prescription. Figure 1 identifies the domains and common symptoms and impairments that 
impact exercise prescription.  
Cardiometabolic Status






























































Cardiometabolic conditions are common pre-existing conditions in individuals with cancer that 
influence exercise tolerance and safety.32-34 Pre-existing conditions may be exacerbated by 
cancer medical treatments and further suppress an individual’s ability to be physically active. 
Furthermore, cancer treatments may incite new cardiovascular risk factors and cardiovascular 
events in previously healthy individuals.35 In general, cardiovascular events, including stroke 
and myocardial infarction, are common causes of premature morbidity and mortality in cancer 
survivors.36-38 Risk assessment in this domain should consider the presence of cardiometabolic 
conditions, pre-existing and emerging, as well as the risk for cancer treatment-related 
cardiotoxicity. These conditions present barriers to exercise and introduce safety considerations 
when developing an exercise prescription. Risk assessment in this domain can determine if 
supervised exercise and clinical monitoring is indicated.39
Oncologic Factors
Cancer treatments impact multiple body systems and cause short and long-term sequelae. The 
nature and severity of side effects are quite varied across the cancer care continuum and differ 
substantially between individuals. Symptoms such as fatigue, restricted joint mobility, 
lymphedema, peripheral neuropathies, musculoskeletal arthralgias, sarcopenia, bone 
degradation and osseous fragility, incontinence, and many others are common40,41 and often 
cause physical impairments that challenge an individual’s tolerance to physical activity.42 While 
this symptom burden is anticipated during antineoplastic therapies, late effects such as pain, 
chronic fatigue, gait instability, and bone degradation also introduce challenges to physical 
activity participation and adherence beyond the completion of treatment.43






























































Risk assessment in this domain should consider the severity of treatment side effects, 
how they progress or regress during treatment, and should monitor for an accumulated burden 
of side effects over the course of treatment. This warrants ongoing, repeated assessment at 
medically important time points through the cancer continuum to inform adaptations to 
exercise interventions. 
Age and Comorbidity
Older adults with cancer are more likely to have functional limitations compared to cancer-free 
controls 10 and many of these limitations become more severe as a result of cancer 
treatment.11,12 Functional limitations precipitate additional barriers to exercise and 
participation in physical activity. The field of geriatric oncology recommends special 
consideration for older individuals44 regarding accelerated muscle loss, cognitive deficits, 
decreased aerobic capacity, and other geriatric syndromes such as frailty.45,46 Characterizing 
risk in this domain guides the selection of optimal interventions that enhance function and 
improve participation in physical activity. The exercise prescription needs to be tailored and 
gradually progressed in a supervised manner to maximize efficacy, safety, and tolerability.
Behavioral Characteristics
The most commonly cited reasons for not engaging in physical activity in the general population 
include lack of time, energy, and motivation.13 Individuals living with and beyond cancer 
experience even greater behavioral barriers to engaging in physical activity. Low energy, time 
stress from multiple appointments, and the stress of dealing with a potentially fatal condition 
exacerbate barriers to physical activity participation.47,48 Moreover, psychosocial factors such as 
motivational readiness, self-efficacy, and social support, contribute to whether an individual 






























































engages in physical activity.49 Assessment in this domain should evaluate the individual’s 
readiness to receive information about physical activity, confidence in their ability to exercise, 
perceived barriers, and preferences for exercise types. Some individuals may possess high self-
efficacy, however their confidence is diminished by fears that exercise will harm them or 
worsen side effects.  Conversely, some individuals have little or no experience with exercise and 
lack sufficient self-efficacy to independently adopt and sustain exercise habits. Assessment in 
this domain aligns individual preferences with evidence based exercise interventions.50 
Environmental Elements
The environment in which individuals live influences their ability to adopt and sustain a 
physically active lifestyle. Environmental issues include the built environment in which one lives 
as well as their work environment, socioeconomic status, financial status, family support, 
health care insurance, access to care, and other social determinants that impact lifestyle and 
behavior.51,52 If an individual does not live in an accessible or safe community, is employed in 
multiple jobs working many hours, or has limited access to health and wellness facilities, they 
are at high risk for physical inactivity.53 Further complicating the environmental domain is the 
issue of access to and payment for medical care. Cancer treatment often incites financial 
toxicity54 which may limit the ability to afford copayments for exercise interventions or to pay 
for gym or recreational facility memberships.55 Risk assessment of environmental elements is 
important for promoting physical activity because the environment an individual lives and 
works in will influence their ability and willingness to engage in exercise. Assessment in this 
domain encourages exercise referrals according to individual needs and preferences that best 
fit the environmental circumstances. 































































The five domains offer a framework to simply and efficiently assess elements most relevant to 
identify decreasing physical activity and inform a clinical pathway for exercise referral. 
Oncology clinicians are in the ideal position to conduct repeated screenings with patients 
through the continuum of cancer care. Primary care and other advanced practice providers also 
play a critical role in recognizing changes across these domains that should prompt referral.  
Many individuals will have a constellation of factors that increase risk, and healthcare providers 
should consider the aggregate burden that exists at the confluence of these domains to inform 
their clinical decision.
The algorithm in Figure 2a provides simple screening questions across the five domains that 
open the conversation about exercise advice and enable referral. The algorithm accomplishes 
two important aspects of patient activation. First, it engages the individual in meaningful 
dialogue about the importance of exercise. All individuals should be counseled on the 
recommended physical activity guidelines and encouraged to maintain levels of activity during 
cancer treatment.56 When an oncology provider encourages exercise, patients are more likely 
to pursue the intervention.6,57  Second, it enables a quick screen of the five domains and a 
clinical decision about the appropriate exercise pathway most aligned with the individual’s 
needs.57 The goal of the algorithm is to enable a provider to quickly delineate between those 
who will benefit from an exercise prescription compared to those who will benefit from other 
services. More specific questions that characterize factors impacting the individual’s ability to 
and willingness to exercise would be introduced in a detailed assessment by the exercise or 
rehabilitation professional.  






























































The endpoints of the algorithm are intended to reflect the spectrum of complexity of 
the individual’s condition and the anticipated level of supervision and guidance that may be 
needed for successful exercise prescription with green representing lower complexity and 
risk/lower need for support and red representing higher complexity and risk/greater need for 
support. When treatment-related symptoms and impairments become persistent or severe 
they present barriers to exercise and may be an early sign of emerging functional morbidity.40,47 
Screening for symptoms or impairments and assessing their severity provides insight on the 
level of intervention that is safe and effective to overcome barriers and promote improvements 
in physical activity. In situations of low complexity (green/yellow spectrum), independent 
exercise or supervised programs led by cancer exercise trainers are effective to increase 
exercise engagement.49 Moderate to high complexity situations (orange/red spectrum) pose 
barriers to exercise and warrant referral to an exercise or rehabilitation professional.23,58
The presence and severity of cancer treatment-related symptoms are routinely 
measured throughout disease treatment. Guidelines from the National Comprehensive Cancer 
Network, the American Society for Clinical Oncology, and others identify critical thresholds for 
intervention and suggest evidence-based pathways for symptom management, often including 
exercise.59-61 While it is beyond the scope of this manuscript to detail symptom management 
guidelines and referral thresholds, providers should be aware of these evidence-based 
recommendations and use them to objectively execute referrals along this exercise pathway. 
Motivation and self-efficacy are important considerations when making exercise 
recommendations. Individuals may not be ready to change their behaviors nor interested in 
taking on exercise if they were not previously active. Acceptance of the individual’s preferences 






























































fosters better provider/patient relations that could eventually facilitate future health behaviors 
and prompt engagement in exercise.47 Safety with exercise and fear of doing harm to oneself by 
‘overdoing it’ requires discussion with a cancer exercise specialist. Exercise and rehabilitative 
professionals have expertise in motivational strategies to enable individual self-activation 
towards exercise, as well as knowledge of safety considerations with exercise prescription, 
further supporting the need for referrals to exercise specialists. Undeniably, the suitability of 
these pathways is negated if the patient is not able to access or afford the prescribed care.  
Thus, assessing environmental and resource constraints and identifying resources that can 
overcome them is critical.
Referral Pathways
The screening algorithm can prompt advice and timely referrals for the most appropriate 
exercise intervention based on the individual’s presentation. Figure 2b describes the level of 
stepped care that is likely to be suited to the individual’s needs, based on the complexity of the 
individual’s condition, as identified through the screening algorithm, using the color scheme of 
green indicating low complexity and red indicating high complexity. 
Exercise Recommendations
Exercise is effective across many different disease types and positively impacts multiple body 
systems.20 Rehabilitative exercise that targets mobility, ADL and IADL performance, return to 
work, and role participation are well substantiated in the literature.62 It is beyond the scope of 
this paper to outline specific exercise interventions. The recently revised ACSM exercise 
guidelines for cancer survivors provide evidence-based recommendations for physical activity, 
outline preferred condition-based exercise prescriptions, and provide guidance for exercise 






























































implementation.56,57,63 Supportive care systems that include proactive exercise and 
rehabilitation enhance medical outcomes.64,65 
Implementation
Achieving implementation of this framework requires enhancements to oncology clinical 
workflows, technology utilization, and professional education programs.65-68 
Clinical Workflows
Survivorship care programs are evolving in clinical oncology care due to recent changes 
in accreditation standards.69 The survivorship care team is ideally positioned to use the 
screening algorithm throughout cancer care and to improve access to supportive care services 
including exercise. Implementation strategies to integrate the screening tool into oncology 
practice include leveraging patient navigation frameworks for screening and exercise 
referrals,70 use of patient reported outcomes measures to identify symptom changes that 
warrant referrals,71 and prospective supportive care services from the point of diagnosis.23,72 
Co-located services with same day appointments for on-site supportive care intervention 
promotes earlier engagement and improves patient outcomes and satisfaction.73 
Technology
Technology offers numerous opportunities for personalized exercise pathways. Electronic 
health records (EHR) can prompt use of the exercise screening tool and provide links to 
appropriate referrals based on findings. EHRs could be setup to prompt screening questions 
when entering vital signs and can integrate this information as a report to simplify assessment 
across the five domains.






























































Electronic assessment tools that use Item Response Theory (IRT)-based Computerized 
Adapted Testing (CAT) are gaining evidence base and clinical traction. These self-reported 
assessments are low burden and provide a precise reflection of the individual’s needs.74 IRT-
based research demonstrates the ability to predict functional decline and disablement in 
advanced cancers, an important construct to support the prospective framework that we 
propose here.75,76 Precision exercise prescription can be driven by these tools’ ability to 
accurately characterize the individual’s level of function and promote tailored exercise 
recommendations.71
Telehealth and telecommunication technologies may be efficient options for delivering 
exercise interventions remotely. 77 Studies in cardiac rehabilitation observe that physical 
activity increased with telehealth cardiac exercise programs.78 Mobile health (mHealth) using 
mobile devices, such as smart phones and wireless physiologic sensors, could deliver an 
exercise intervention any time and any place and allow remote monitoring of progress and 
physical measures, such as heart rate, enabling direct provider to patient interaction with 
feedback and support in near-real-time. These applications could reduce many barriers of face-
to-face interactions, such as cost, transportation, access to an exercise facility, and geographic 
isolation.79
An ideal technology platform would offer individuals with cancer multiple, evidence-
based options to meet their specific exercise needs and would adhere to their preferences with 
consideration for their current state of health and physical ability. A platform that provides 
individualized recommendations will likely enhance acceptability, care delivery, and 
engagement in exercise. However, technology can also negatively impact care by fragmenting 






























































services, increasing provider workloads, and contributing to burnout. Further it may frustrate 
patients if the interface is not user-friendly or if the output is not perceived as helpful. While it 
is outside of the scope of this commentary to review this literature, it is important to consider 
technology in the context of clinical workflows and in terms of the application’s acceptability to 
patients and providers.
Education
The education of oncology health care professionals must evolve regarding the current 
evidence and exercise guidelines if implementation is to succeed. Continuing education 
programs must train oncology health care professionals to know how and when to assess, and 
where to refer cancer survivors for exercise programs. Moreover, raising the knowledgebase of 
health care professionals across primary care and other disciplines is of paramount importance 
to assure that long-term needs are met. 
Professional degree programs should incorporate cancer exercise evidence into their 
curriculum. Nurses, patient navigators, and community-based providers need stronger 
knowledge of the benefits and safety of exercise to counsel patients during and following 
treatment. Physicians and oncology advanced practice professionals need to be comfortable 
screening and referring appropriately. The algorithm herein identifies screening questions and 
provides prompts towards an exercise clinical pathway.  Ideally, oncology professionals will 
discuss exercise with their patients, but this may not always be feasible and therefore the 
referral pathway to rehabilitation or exercise professionals may be optimal from a time 
management perspective.70






























































At present, most exercise science and rehabilitation discipline education curriculum do 
not have ample content in oncology and exercise prescription. There are emerging models for 
educational curriculum including Masters’ degree programs in Cancer Care* and oncology 
residency training programs in physiatry and physical therapy.  Recently the Clinical Oncology 
Society of Australia (COSA) recommended that exercise become a standard of care in oncology 
across all disease states, incorporated in cancer care from the time of diagnosis.80 This has 
accelerated educational curriculum development and integrated exercise assessment into 
clinical workflows. ACSM’s Exercise is Medicine seeks to advance the dissemination and 
implementation of the cancer exercise guidelines through the Moving Through Cancer† 
initiative. However, significant changes are needed in exercise physiology curriculum to 
enhance knowledge and skills in cancer exercise among their graduates. Integrating curriculum 
changes, providing in-depth training opportunities and elevating awareness across disciplines 
are necessary steps to enhance implementation. 
Integration to Practice: A Call to Action
A new standard of practice in cancer care is warranted due to the improvement in 
outcomes evident when exercise is integrated into cancer care from diagnosis through 
treatment. The value proposition of prospective personalized exercise clinical pathways in 
oncology is that they promote early detection of physical decline and prompt exercise 
interventions that mitigate or ameliorate many cancer treatment-related symptoms, reduce 
impairment and disability,81,82 enhance return to work and social roles,83,84 and positively 
* https://www.francis.edu/Master-of-Cancer-Care/
† https://www.exerciseismedicine.org/support_page.php/moving-through-cancer/ 






























































influence health endpoints such as infection rates, hospitalization rates, and chemotherapy 
tolerability in some populations.85-87 The proposed five domains offer a framework for efficient 
and effective screening that enables exercise referrals best suited to an individual’s existing and 
evolving needs. The time is now for oncology professionals to adopt this framework and to start 
building the technical tools and systems to enhance healthcare professionals’ ability to engage 
patients around exercise and physical activity recommendations. 
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There are approximately 17 million cancer survivors living in the United States and by 2040 this 
estimate is predicted to increase to 26.1 million.1 Exercise provides a myriad of health benefits 
to individuals during and after cancer treatment by reducing treatment-related symptoms, 
improving functional status and quality of life, and lowering risk of disease recurrence.2,3 
Despite the established benefits, an individual’s level of physical activity often decreases during 
treatment and does not return to pre-diagnosis levels after treatment completion.4,5 While 
exercise is regarded as safe and beneficial for individuals with cancer, promoting exercise for 
this population is complex. A patient-centered pathway is needed that can guide oncology and 
primary care professionals in efficient assessment of an individual’s condition and enable 
personalized referrals for exercise interventions that promote physical activity. The purpose of 
this manuscript is to provide a framework for clinical decision making that enables personalized 
condition assessment, risk stratification, and referral to optimal settings for exercise promotion 
for cancer survivors. Implementation strategies are also offered to support the integration of 
this model into an oncology clinical workflow.
With guidance from their medical provider, individuals are more likely to engage in 
exercise and maintain levels of physical activity during cancer treatments.6 However, the 
number of individuals with cancer who report receiving exercise-specific guidance from their 
health care providers is low.7 Of particular concern is the lack of knowledge and training among 
health care professionals about exercise prescription for this complex population.8
Condition Complexity and Exercise Prescription 






























































The concurrence of cancer treatment-related side effects with pre-existing health conditions 
often makes it difficult for individuals to engage in physical activity and exercise.9-12 
Furthermore, motivation,13 environmental constraints, and concerns about safety during cancer 
medical therapies are barriers that challenge exercise engagement.14 15 In the case of exercise, 
it is widely recognized that one size does not fit all. A safe and well-designed exercise 
prescription for an individual at one point in the treatment continuum may not be safe or 
tenable further into treatment. Cancer care is dynamic and warrants personalized treatment 
pathways that individualize interventions, particularly regarding exercise, as the individual’s 
medical status and personal needs change.16-18 
Characterizing the individual’s prior level of function, exercise habits and lifestyle 
behaviors, preexisting comorbid conditions, and environment at the point of diagnosis provides 
important context to inform personalized exercise recommendations. A pragmatic approach to 
promote exercise is to then repeatedly screen for clinically meaningful changes in these 
baseline measures and refer for exercise prescription when indicated. Proactively prescribing 
exercise throughout cancer treatment may prevent the onset of some symptoms and mitigate 
the progressive severity of treatment-related functional impairments.19,20 
Numerous care models promote proactive assessment and referral for exercise and 
rehabilitation interventions for individuals with cancer. These models address referral based on 
presence of physical and functional impairment,21-23 age-related senescence,24 adverse side 
effects of cancer treatments,25,26 and many propose skilled interventions based on level of risk 
for treatment-related functional decline27-30 or impairment burden.18,31 Our core author team 
(NS/JB/TM/AS) conducted an evidence review of these models and identified common 






























































components that promoted prospective assessment for rehabilitative and exercise referrals 
in oncology specifically identifying evidence for risk stratification, screening and assessment, 
triage concepts and pathways, and implementation strategies. These findings were reviewed 
with the entire author team over the course of two teleconference discussions. The decision 
was made by consensus to work in teams to synthesize the evidence to support an exercise 
clinical pathway focusing on (i) screening for risk stratification (JB/KBE/JM/JL), (ii) referral 
pathways (NS/CA/JS/DZ), and (iii) implementation (AS/KS/LN/AC). These three areas were 
prioritized as the most impactful to guiding oncology or primary care professionals in 
promoting exercise referral. The concept of individual assessment for exercise interventions 
(TM/AC/GC/KC) informed the final manuscript but was decided to be beyond the scope of 
this manuscript and will be addressed in future work. Based on this review, we propose five 
domains to inform a personalized exercise clinical pathway. 
Five Domains to Guide Decision Making 
The five domains provide perspective on the complexity of an individual’s condition, 
characterize risk for exercise-related complications, and guide clinical decision making for 
individualized recommendations. The domains include cardiometabolic status, oncologic 
factors, aging considerations, behavioral characteristics, and environmental elements. The 
confluence of presenting symptoms within and across domains influences the exercise 
prescription. Figure 1 identifies the domains and common symptoms and impairments that 
impact exercise prescription.  
Cardiometabolic Status






























































Cardiometabolic conditions are common pre-existing conditions in individuals with cancer that 
influence exercise tolerance and safety.32-34 Pre-existing conditions may be exacerbated by 
cancer medical treatments and further suppress an individual’s ability to be physically active. 
Furthermore, cancer treatments may incite new cardiovascular risk factors and cardiovascular 
events in previously healthy individuals.35 In general, cardiovascular events, including stroke 
and myocardial infarction, are common causes of premature morbidity and mortality in cancer 
survivors.36-38 Risk assessment in this domain should consider the presence of cardiometabolic 
conditions, pre-existing and emerging, as well as the risk for cancer treatment-related 
cardiotoxicity. These conditions present barriers to exercise and introduce safety considerations 
when developing an exercise prescription. Risk assessment in this domain can determine if 
supervised exercise and clinical monitoring is indicated.39
Oncologic Factors
Cancer treatments impact multiple body systems and cause short and long-term sequelae. The 
nature and severity of side effects are quite varied across the cancer care continuum and differ 
substantially between individuals. Symptoms such as fatigue, restricted joint mobility, 
lymphedema, peripheral neuropathies, musculoskeletal arthralgias, sarcopenia, bone 
degradation and osseous fragility, incontinence, and many others are common40,41 and often 
cause physical impairments that challenge an individual’s tolerance to physical activity.42 While 
this symptom burden is anticipated during antineoplastic therapies, late effects such as pain, 
chronic fatigue, gait instability, and bone degradation also introduce challenges to physical 
activity participation and adherence beyond the completion of treatment.43






























































Risk assessment in this domain should consider the severity of treatment side effects, 
how they progress or regress during treatment, and should monitor for an accumulated burden 
of side effects over the course of treatment. This warrants ongoing, repeated assessment at 
medically important time points through the cancer continuum to inform adaptations to 
exercise interventions. 
Age and Comorbidity
Older adults with cancer are more likely to have functional limitations compared to cancer-free 
controls 10 and many of these limitations become more severe as a result of cancer 
treatment.11,12 Functional limitations precipitate additional barriers to exercise and 
participation in physical activity. The field of geriatric oncology recommends special 
consideration for older individuals44 regarding accelerated muscle loss, cognitive deficits, 
decreased aerobic capacity, and other geriatric syndromes such as frailty.45,46 Characterizing 
risk in this domain guides the selection of optimal interventions that enhance function and 
improve participation in physical activity. The exercise prescription needs to be tailored and 
gradually progressed in a supervised manner to maximize efficacy, safety, and tolerability.
Behavioral Characteristics
The most commonly cited reasons for not engaging in physical activity in the general population 
include lack of time, energy, and motivation.13 Individuals living with and beyond cancer 
experience even greater behavioral barriers to engaging in physical activity. Low energy, time 
stress from multiple appointments, and the stress of dealing with a potentially fatal condition 
exacerbate barriers to physical activity participation.47,48 Moreover, psychosocial factors such as 
motivational readiness, self-efficacy, and social support, contribute to whether an individual 






























































engages in physical activity.49 Assessment in this domain should evaluate the individual’s 
readiness to receive information about physical activity, confidence in their ability to exercise, 
perceived barriers, and preferences for exercise types. Some individuals may possess high self-
efficacy, however their confidence is diminished by fears that exercise will harm them or 
worsen side effects.  Conversely, some individuals have little or no experience with exercise and 
lack sufficient self-efficacy to independently adopt and sustain exercise habits. Assessment in 
this domain aligns individual preferences with evidence based exercise interventions.50 
Environmental Elements
The environment in which individuals live influences their ability to adopt and sustain a 
physically active lifestyle. Environmental issues include the built environment in which one lives 
as well as their work environment, socioeconomic status, financial status, family support, 
health care insurance, access to care, and other social determinants that impact lifestyle and 
behavior.51,52 If an individual does not live in an accessible or safe community, is employed in 
multiple jobs working many hours, or has limited access to health and wellness facilities, they 
are at high risk for physical inactivity.53 Further complicating the environmental domain is the 
issue of access to and payment for medical care. Cancer treatment often incites financial 
toxicity54 which may limit the ability to afford copayments for exercise interventions or to pay 
for gym or recreational facility memberships.55 Risk assessment of environmental elements is 
important for promoting physical activity because the environment an individual lives and 
works in will influence their ability and willingness to engage in exercise. Assessment in this 
domain encourages exercise referrals according to individual needs and preferences that best 
fit the environmental circumstances. 































































The five domains offer a framework to simply and efficiently assess elements most relevant to 
identify decreasing physical activity and inform a clinical pathway for exercise referral. 
Oncology clinicians are in the ideal position to conduct repeated screenings with patients 
through the continuum of cancer care. Primary care and other advanced practice providers also 
play a critical role in recognizing changes across these domains that should prompt referral.  
Many individuals will have a constellation of factors that increase risk, and healthcare providers 
should consider the aggregate burden that exists at the confluence of these domains to inform 
their clinical decision.
The algorithm in Figure 2a provides simple screening questions across the five domains that 
open the conversation about exercise advice and enable referral. The algorithm accomplishes 
two important aspects of patient activation. First, it engages the individual in meaningful 
dialogue about the importance of exercise. All individuals should be counseled on the 
recommended physical activity guidelines and encouraged to maintain levels of activity during 
cancer treatment.56 When an oncology provider encourages exercise, patients are more likely 
to pursue the intervention.6,57  Second, it enables a quick screen of the five domains and a 
clinical decision about the appropriate exercise pathway most aligned with the individual’s 
needs.57 The goal of the algorithm is to enable a provider to quickly delineate between those 
who will benefit from an exercise prescription compared to those who will benefit from other 
services. More specific questions that characterize factors impacting the individual’s ability to 
and willingness to exercise would be introduced in a detailed assessment by the exercise or 
rehabilitation professional.  






























































The endpoints of the algorithm are intended to reflect the spectrum of complexity of 
the individual’s condition and the anticipated level of supervision and guidance that may be 
needed for successful exercise prescription with green representing lower complexity and 
risk/lower need for support and red representing higher complexity and risk/greater need for 
support. When treatment-related symptoms and impairments become persistent or severe 
they present barriers to exercise and may be an early sign of emerging functional morbidity.40,47 
Screening for symptoms or impairments and assessing their severity provides insight on the 
level of intervention that is safe and effective to overcome barriers and promote improvements 
in physical activity. In situations of low complexity (green/yellow spectrum), independent 
exercise or supervised programs led by cancer exercise trainers are effective to increase 
exercise engagement.49 Moderate to high complexity situations (orange/red spectrum) pose 
barriers to exercise and warrant referral to an exercise or rehabilitation professional.23,58
The presence and severity of cancer treatment-related symptoms are routinely 
measured throughout disease treatment. Guidelines from the National Comprehensive Cancer 
Network, the American Society for Clinical Oncology, and others identify critical thresholds for 
intervention and suggest evidence-based pathways for symptom management, often including 
exercise.59-61 While it is beyond the scope of this manuscript to detail symptom management 
guidelines and referral thresholds, providers should be aware of these evidence-based 
recommendations and use them to objectively execute referrals along this exercise pathway. 
Motivation and self-efficacy are important considerations when making exercise 
recommendations. Individuals may not be ready to change their behaviors nor interested in 
taking on exercise if they were not previously active. Acceptance of the individual’s preferences 






























































fosters better provider/patient relations that could eventually facilitate future health behaviors 
and prompt engagement in exercise.47 Safety with exercise and fear of doing harm to oneself by 
‘overdoing it’ requires discussion with a cancer exercise specialist. Exercise and rehabilitative 
professionals have expertise in motivational strategies to enable individual self-activation 
towards exercise, as well as knowledge of safety considerations with exercise prescription, 
further supporting the need for referrals to exercise specialists. Undeniably, the suitability of 
these pathways is negated if the patient is not able to access or afford the prescribed care.  
Thus, assessing environmental and resource constraints and identifying resources that can 
overcome them is critical.
Referral Pathways
The screening algorithm can prompt advice and timely referrals for the most appropriate 
exercise intervention based on the individual’s presentation. Figure 2b describes the level of 
stepped care that is likely to be suited to the individual’s needs, based on the complexity of the 
individual’s condition, as identified through the screening algorithm, using the color scheme of 
green indicating low complexity and red indicating high complexity. 
Exercise Recommendations
Exercise is effective across many different disease types and positively impacts multiple body 
systems.20 Rehabilitative exercise that targets mobility, ADL and IADL performance, return to 
work, and role participation are well substantiated in the literature.62 It is beyond the scope of 
this paper to outline specific exercise interventions. The recently revised ACSM exercise 
guidelines for cancer survivors provide evidence-based recommendations for physical activity, 
outline preferred condition-based exercise prescriptions, and provide guidance for exercise 






























































implementation.56,57,63 Supportive care systems that include proactive exercise and 
rehabilitation enhance medical outcomes.64,65 
Implementation
Achieving implementation of this framework requires enhancements to oncology clinical 
workflows, technology utilization, and professional education programs.65-68 
Clinical Workflows
Survivorship care programs are evolving in clinical oncology care due to recent changes 
in accreditation standards.69 The survivorship care team is ideally positioned to use the 
screening algorithm throughout cancer care and to improve access to supportive care services 
including exercise. Implementation strategies to integrate the screening tool into oncology 
practice include leveraging patient navigation frameworks for screening and exercise 
referrals,70 use of patient reported outcomes measures to identify symptom changes that 
warrant referrals,71 and prospective supportive care services from the point of diagnosis.23,72 
Co-located services with same day appointments for on-site supportive care intervention 
promotes earlier engagement and improves patient outcomes and satisfaction.73 
Technology
Technology offers numerous opportunities for personalized exercise pathways. Electronic 
health records (EHR) can prompt use of the exercise screening tool and provide links to 
appropriate referrals based on findings. EHRs could be setup to prompt screening questions 
when entering vital signs and can integrate this information as a report to simplify assessment 
across the five domains.






























































Electronic assessment tools that use Item Response Theory (IRT)-based Computerized 
Adapted Testing (CAT) are gaining evidence base and clinical traction. These self-reported 
assessments are low burden and provide a precise reflection of the individual’s needs.74 IRT-
based research demonstrates the ability to predict functional decline and disablement in 
advanced cancers, an important construct to support the prospective framework that we 
propose here.75,76 Precision exercise prescription can be driven by these tools’ ability to 
accurately characterize the individual’s level of function and promote tailored exercise 
recommendations.71
Telehealth and telecommunication technologies may be efficient options for delivering 
exercise interventions remotely. 77 Studies in cardiac rehabilitation observe that physical 
activity increased with telehealth cardiac exercise programs.78 Mobile health (mHealth) using 
mobile devices, such as smart phones and wireless physiologic sensors, could deliver an 
exercise intervention any time and any place and allow remote monitoring of progress and 
physical measures, such as heart rate, enabling direct provider to patient interaction with 
feedback and support in near-real-time. These applications could reduce many barriers of face-
to-face interactions, such as cost, transportation, access to an exercise facility, and geographic 
isolation.79
An ideal technology platform would offer individuals with cancer multiple, evidence-
based options to meet their specific exercise needs and would adhere to their preferences with 
consideration for their current state of health and physical ability. A platform that provides 
individualized recommendations will likely enhance acceptability, care delivery, and 
engagement in exercise. However, technology can also negatively impact care by fragmenting 






























































services, increasing provider workloads, and contributing to burnout. Further it may frustrate 
patients if the interface is not user-friendly or if the output is not perceived as helpful. While 
it is outside of the scope of this commentary to review this literature, it is important to 
consider technology in the context of clinical workflows and in terms of the application’s 
acceptability to patients and providers.
Education
The education of oncology health care professionals must evolve regarding the current 
evidence and exercise guidelines if implementation is to succeed. Continuing education 
programs must train oncology health care professionals to know how and when to assess, and 
where to refer cancer survivors for exercise programs. Moreover, raising the knowledgebase of 
health care professionals across primary care and other disciplines is of paramount importance 
to assure that long-term needs are met. 
Professional degree programs should incorporate cancer exercise evidence into their 
curriculum. Nurses, patient navigators, and community-based providers need stronger 
knowledge of the benefits and safety of exercise to counsel patients during and following 
treatment. Physicians and oncology advanced practice professionals need to be comfortable 
screening and referring appropriately. The algorithm herein identifies screening questions and 
provides prompts towards an exercise clinical pathway.  Ideally, oncology professionals will 
discuss exercise with their patients, but this may not always be feasible and therefore the 
referral pathway to rehabilitation or exercise professionals may be optimal from a time 
management perspective.70






























































At present, most exercise science and rehabilitation discipline education curriculum do 
not have ample content in oncology and exercise prescription. There are emerging models for 
educational curriculum including Masters’ degree programs in Cancer Care* and oncology 
residency training programs in physiatry and physical therapy.  Recently the Clinical Oncology 
Society of Australia (COSA) recommended that exercise become a standard of care in oncology 
across all disease states, incorporated in cancer care from the time of diagnosis.80 This has 
accelerated educational curriculum development and integrated exercise assessment into 
clinical workflows. ACSM’s Exercise is Medicine seeks to advance the dissemination and 
implementation of the cancer exercise guidelines through the Moving Through Cancer† 
initiative. However, significant changes are needed in exercise physiology curriculum to 
enhance knowledge and skills in cancer exercise among their graduates. Integrating curriculum 
changes, providing in-depth training opportunities and elevating awareness across disciplines 
are necessary steps to enhance implementation. 
Integration to Practice: A Call to Action
A new standard of practice in cancer care is warranted due to the improvement in 
outcomes evident when exercise is integrated into cancer care from diagnosis through 
treatment. The value proposition of prospective personalized exercise clinical pathways in 
oncology is that they promote early detection of physical decline and prompt exercise 
interventions that mitigate or ameliorate many cancer treatment-related symptoms, reduce 
impairment and disability,81,82 enhance return to work and social roles,83,84 and positively 
* https://www.francis.edu/Master-of-Cancer-Care/
† https://www.exerciseismedicine.org/support_page.php/moving-through-cancer/ 






























































influence health endpoints such as infection rates, hospitalization rates, and chemotherapy 
tolerability in some populations.85-87 The proposed five domains offer a framework for efficient 
and effective screening that enables exercise referrals best suited to an individual’s existing and 
evolving needs. The time is now for oncology professionals to adopt this framework and to start 
building the technical tools and systems to enhance healthcare professionals’ ability to engage 
patients around exercise and physical activity recommendations. 
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Figure 1. Five Domains that Inform Assessment for Exercise Referrals and Prescription 
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Figure 2a. Algorithm for an exercise referral clinical pathway*
*The pathway is intended to stratify individuals to higher (red) or lower (green) condition complexity which 
provides insight to the level of supervision and guidance they may need to successfully engage in exercise 
and informs referrals to setting outlined in 2b. 
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Figure 2b. Suggested Exercise Settings and Supervision Based on Individual Condition Complexity and Risk 
for Decline. 
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